Tysabri - Therapeutic Monoclonal Antibody (MAb) for the Treatment of Multiple Sclerosis

Print

Damage to the myelin sheath disrupts signals between the brain and other parts of the body producing a range of symptoms.
 
«Back | Next»

Return to Profile




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development